Nitto Avecia’s Milford Facility Receives FDA No Action Indicated Classification Following cGMP Inspection Nitto Avecia, a contract development and manufacturing organization (CDMO) specializing in oligonucleotide therapeutics, announced that the U.S. Food and Drug Administration (FDA) has classified its recently completed…
Exthymic Receives Up to $25 Million ARPA-H Award to Advance LITTLESTAR Cell Therapy Manufacturing Device Exthymic Corporation, a biotechnology company developing technologies designed to expand access to engineered cell therapies, announced that it has been awarded a contract from the…
I2Pure Expands Leadership and Scientific Team to Support Molecular Iodine Manufacturing and Research Growth I2Pure Corp., a biotechnology company focused on patented molecular iodine (I₂) technology for antimicrobial and antiseptic applications, has announced the addition of three experienced professionals to…
Singleton Associates and Blue Cross and Blue Shield of Texas Reach Multi-Year Agreement to Maintain In-Network Radiology Access Singleton Associates, P.A. (Singleton Associates), a radiology practice affiliated with Radiology Partners, and Blue Cross and Blue Shield of Texas (BCBSTX) have…
Summit Therapeutics, Daiichi Sankyo and AstraZeneca Launch Clinical Collaboration to Evaluate Ivonescimab and Datroway in Solid Tumors Summit Therapeutics Inc. (Nasdaq: SMMT) has announced a clinical trial collaboration agreement with Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/NYSE: AZN) to investigate…
Samsung Bioepis and Teva Expand Global Biosimilar Partnership to Advance Up to Six Candidates Samsung Bioepis Co., Ltd. and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) have announced an expanded strategic collaboration to develop and commercialize up to six…
As artificial intelligence moves from pilot projects to everyday practice across the life sciences industry, the Medical Affairs Professional Society (MAPS) will bring together leaders from pharma, biotech and MedTech for the 2026 Medical Affairs Technology and Innovation Symposium on…
Qurient Study in Science Advances Shows Q901 Can Enhance TOP1-Targeting ADC Activity Qurient Co., Ltd. (KRX: 115180), a clinical-stage biotechnology company focused on developing innovative cancer therapies, has announced the publication of a peer-reviewed study in Science Advances demonstrating the…
SpecialtyCare’s IONM Training Program Earns CAAHEP Accreditation, Advancing Clinical Education and Patient Safety SpecialtyCare, a leading provider of outsourced clinical services in the United States, has announced that its Intraoperative Neuromonitoring (IONM) Training Program has received accreditation from the Commission…
Junevity and Amorepacific Partner to Develop Next-Generation Skin Rejuvenation Cosmetics Junevity, a biotechnology company focused on extending human lifespan and healthspan, has entered into a strategic collaboration with Amorepacific Corporation, a global beauty and wellness company, to explore new approaches…
TECPR2 Research Foundation and Forge Biologics Partner to Advance AAV Gene Therapy for Ultra-Rare Neurological Disease The TECPR2 Research Foundation, a nonprofit organization focused on advancing research and development of treatments for patients affected by TECPR2-related disease, has announced a…
Alcon Launches Systane PRO Preservative-Free in Canada With Up to 12 Hours of Dry Eye Relief Alcon, a global leader in eye care, has announced the Canadian launch of Systane® PRO Preservative-Free (PF), the company’s most advanced Systane formulation to…